Inhibikase Therapeutics, INC. (IKT) SEC Filings — 2025
18 SEC filings for Inhibikase Therapeutics, INC. (IKT) in 2025.
Filings
- Inhibikase Therapeutics, INC. 8-K Filing — 8-K · Dec 19, 2025
- Inhibikase Therapeutics, INC. 8-K Filing — 8-K · Nov 21, 2025
- Inhibikase Therapeutics Files 8-K Report — 8-K · Nov 20, 2025
- Inhibikase Losses Mount Amid Soaring R&D for PAH Drug — 10-Q · Nov 14, 2025
- Inhibikase Losses Soar 145% on R&D Boost, Cash Position Strong — 10-Q · Aug 14, 2025
- Inhibikase Therapeutics Reports Shareholder Vote — 8-K · Jun 30, 2025
- Inhibikase Therapeutics Files Proxy Statement Supplement — DEFA14A · Jun 12, 2025
- Inhibikase Therapeutics Files 8-K on Financials — 8-K · May 14, 2025
- Inhibikase Therapeutics Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Inhibikase Therapeutics Files 2025 Proxy Statement — DEF 14A · May 12, 2025
- Inhibikase Therapeutics Files 10-K/A Amendment — 10-K/A · Apr 25, 2025
- Inhibikase Therapeutics Announces Corporate Changes — 8-K · Apr 14, 2025
- Inhibikase Therapeutics Files 8-K on Financials — 8-K · Mar 27, 2025
- Inhibikase Therapeutics Files 2024 10-K — 10-K · Mar 27, 2025
- Inhibikase Therapeutics Files 8-K with Key Corporate Updates — 8-K · Feb 24, 2025
- Inhibikase Therapeutics Files 8-K on Officer/Director Changes — 8-K · Feb 18, 2025
- Inhibikase Therapeutics Files 8-K Report — 8-K · Jan 29, 2025
- Inhibikase Therapeutics Files 8-K — 8-K · Jan 6, 2025